Tips for Understanding Pediatric Ocular Tumors
Carol L. Shields, MD; Jerry A. Shields, MD
Ocular Oncology Service at Wills Eye Hospital
Philadelphia, PA 19107
Purpose/Relevance: Ocular tumors are well known to masquerade as non-malignant conditions. The clinician cannot afford to miss an ocular tumor, particularly in a child.
Target Audience: Pediatric Ophthalmologists & General Ophthalmologists
Current Practice: Pediatric ophthalmologists are often the first clinicians to evaluated a child with an ocular tumor. With the limited time available, the ophthalmologist must recognize and plan how to co-manage this case.
Best Practice: Recognition of important clinical features, treatment options, and expected outcomes for children with ocular tumors
Expected Outcomes: At the conclusion of this presentation, attendees should be able to recognize characteristic clinical features of the spectrum of pediatric ocular tumors. The attendee should be able to understand the reasoning for specific treatment approaches.
Format: Didactic lecture with audience participation
Summary: A quick overview of the most important pediatric ocular tumors will be presented to provide up-to-date information on tumors of the eyelid, conjunctiva, intraocular structures, and orbit.
References: Shields CL, Sioufi K, Alset AE, et al . Conjunctival tumors in children in 806 cases. Analysis of demographic influence and features differentiating benign from malignant tumors. JAMA Ophthalmol 2017;in press.
Shields CL, Lally SE, Leahey AM, Jabbour PM, Caywood EH, Schwendeman R, Shields JA. Targeted retinoblastoma management. When to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol 2014;25:374-85.
Shields CL, Jorge R, Say EAT, Magrath G, Al Set A, Leahey AM, Caywood E, Jabbour P, Shields JA. Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the International Classification of Retinoblastoma. Asia Pac J Ophthalmol 2016;5:97-103.